Pendekatan Farmakologi Klinis Melalui Farmakogenomik Pada Era Pengobatan Presisi

HY, Jefman Efendi Marzuki and Gayatri, Anggi (2023) Pendekatan Farmakologi Klinis Melalui Farmakogenomik Pada Era Pengobatan Presisi. Prominentia Medical Journal, 4 (2). pp. 42-55. ISSN 2746-7856; e-ISSN 2746-5357

PDF Jefman Efendi MArzuki HY_PENDEKATAN FARMAKOLOGI KLINIS.pdf Download (1MB)

Abstract

One of the factors contributing to patient morbidity and death is variable variability in treatment response. Adverse drug responses (ADRs) or subtherapeutic effects are possible in certain patients during medication administration. The genetic variation is one of the many variables that contribute to this condition. Pharmacogenomics is the study of how genes influence an individual's response to drugs. The goal of pharmacogenomics  is to optimise treatment for the patient. It has been established that a number of genes are associated with drug response, which affects both the direct effects of drugs (pharmacodynamics) and their blood levels (pharmacokinetics). Modifications to a medication's pharmacokinetics and pharmacodynamics may result in toxicity or lessen its efficacy. In order to increase the precision of pharmacotherapy techniques, this study aims to elucidate the availability of data on genetic variants that are known to affect medication response.

Item Type:	Article
Additional Information:	Number: 2
Uncontrolled Keywords:	Preventive Medicine, the Prevention of Lifestyle Diseases.
Subjects:	R Medicine > RM Therapeutics. Pharmacology
Divisions:	Faculty of Medical
Depositing User:	JEFMAN EFENDI MARZUKI H.Y.
Date Deposited:	10 Jan 2024 03:07
Last Modified:	06 Feb 2024 08:36
URI:	http://repository.ubaya.ac.id/id/eprint/45663

Actions (login required)

View Item